Table 2.
Angiography and revascularization
| Levosimendan mandatory n =46 | Levosimendan contraindicated n = 48 | P-value | |
|---|---|---|---|
| Angiography findings | |||
| One-vessel disease, n (%) | 11 (23.9) | 9 (18.8) | 0.53 |
| Multi-vessel disease, n (%) | 26 (56.5) | 32 (66.7) | 0.44 |
| Left main disease, n (%) | 9 (19.6) | 7 (14.5) | 0.51 |
| Number of treated segments | |||
| LM, n (%) | 2 (1.9) | 8 (6.6) | 0.11 |
| LAD, n (%) | 48 (45.3) | 42 (34.7) | 0.13 |
| LCx, n (%) | 24 (22.6) | 29 (23.9) | 0.88 |
| RCA, n (%) | 32 (30.2) | 42 (34.7) | 0.48 |
| Saphenous graft, n (%) | 0 (0.0) | 1 (0.1) | 0.31 |
| Compl. revasc., n (%) | 23 (50.0) | 19 (39.6) | 0.31 |
| Success. proc., n (%) | 43 (93.5) | 41 (85.4) | 0.20 |
Abbreviations: Compl. revasc., completeness of revascularization; LAD, left anterior descending artery; LCx, left circumflex artery; LM, left main; RCA, right coronary artery; Success. proc., successful procedure.